In vivo-in vitro evaluation of the impact of accelerated stability conditions on a hydrophilic matrix tablet.
Stark
P
P
IVIVR Co-operative Working Group, Elan Corporation plc, Athlone, Co. Westmeath, Ireland.
Kinahan
A
A
Cunningham
S
S
Farrell
C
C
Butler
J
J
Reilly
M
M
Devane
J
J
D003692:Delayed-Action Preparations / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics*; D004355:Drug Stability; D006801:Humans; D006813:Humidity; D065347:Hypromellose Derivatives; D066298:In Vitro Techniques; D008747:Methylcellulose / Q000031:analogs & derivatives; D004364:Pharmaceutical Preparations / Q000145:classification; D013607:Tablets; D013718:Tensile Strength
D003692:Delayed-Action Preparations; D004364:Pharmaceutical Preparations; D013607:Tablets; D065347:Hypromellose Derivatives; D008747:Methylcellulose